Early research (Phase 1)UnknownNCT02546739What this trial is testingImmunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLLWho this might be right forLeukemiaLymphoma Beijing Doing Biomedical Co., Ltd. 100
Early research (Phase 1)Active Not RecruitingNCT03913949What this trial is testingEvaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic MalignanciesWho this might be right forChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Ascentage Pharma Group Inc. 74
Testing effectiveness (Phase 2)Study completedNCT00987493What this trial is testingRituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell LymphomaWho this might be right forLymphoma Swiss Cancer Institute 49
Early research (Phase 1)Temporarily pausedNCT00077493What this trial is testingBL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma MedImmune LLC 95
Not applicableStudy completedNCT00900484What this trial is testingSWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 458
Testing effectiveness (Phase 2)Study completedNCT00241358What this trial is testingStudy Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological MalignanciesWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more Washington University School of Medicine 92
Early research (Phase 1)Study completedNCT00054236What this trial is testingCombination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Case Comprehensive Cancer Center 55
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Early research (Phase 1)UnknownNCT00004036What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more The Cleveland Clinic 30
Early research (Phase 1)Study completedNCT00020111What this trial is testingArsenic Trioxide in Treating Young Patients With Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00053963What this trial is testingFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00001271What this trial is testingA Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell LymphomaWho this might be right forB Cell Lymphoma National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05806099What this trial is testingA Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHLWho this might be right forNon-Hodgkin's Lymphoma Beijing Mabworks Biotech Co., Ltd. 132
Large-scale testing (Phase 3)Ended earlyNCT00014326What this trial is testingInvolved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 204
Very early researchEnded earlyNCT00020670What this trial is testingVaccine Therapy in Treating Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Dana-Farber Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT03259529What this trial is testingSafety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCLWho this might be right forDiffuse Large B Cell Lymphoma St. Petersburg State Pavlov Medical University 30
Early research (Phase 1)Study completedNCT02996773What this trial is testingHaploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more University of Arizona 50
Testing effectiveness (Phase 2)UnknownNCT04948788What this trial is testingSHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forRecurrent and Refractory B-cell Non-Hodgkin's Lymphoma Jiangsu HengRui Medicine Co., Ltd. 102
Early research (Phase 1)Study completedNCT02219737What this trial is testingIbrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forCD20 PositiveRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma National Cancer Institute (NCI) 26
Early research (Phase 1)UnknownNCT03383952What this trial is testingA Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and LeukemiaWho this might be right forB Cell LeukemiaB Cell Lymphoma Immune Cell, Inc. 20